Processa Pharmaceuticals, Inc. Senior Notes, Current
Processa Pharmaceuticals, Inc. (PCSA) had Senior Notes, Current of $762.23 thousand as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current › Long-Term Debt, Current Maturities › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:SeniorNotesCurrent · last filed 2021-03-25
- 2020-09-30: Senior Notes, Current $762.23K.
- 2020-06-30: Senior Notes, Current $804.64K.
- 2020-03-31: Senior Notes, Current $803.57K.
- 2019-12-31: Senior Notes, Current $802.50K.
| Period end | Senior Notes, Current |
|---|---|
| 2020-09-30 | $762.23K 10-Q · filed 2020-11-12 |
| 2020-06-30 | $804.64K 10-Q · filed 2020-08-05 |
| 2020-03-31 | $803.57K 10-Q · filed 2020-05-15 |
| 2019-12-31 | $802.50K 10-K · filed 2021-03-25 |
| 2019-06-30 | $230.00K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $230.00K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $230.00K 10-K · filed 2020-03-06 |
| 2018-09-30 | $227.77K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $224.06K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.48M 10-Q · filed 2018-05-21 |
| 2017-12-31 | $2.45M 10-K/A · filed 2019-04-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |